article thumbnail

Hospitals and Medical Device Manufacturers Must Work Together on Cybersecurity

MedCity News

Greater collaboration among healthcare providers, medical device manufacturers, and lawmakers and regulators will lead to predictability and consistency in cybersecurity management. Together, we can make even greater strides toward patient safety and a more secure and sustainable healthcare system.

article thumbnail

Patent expiration to drive biosimilars market expansion to 2032

European Pharmaceutical Review

Expirations of biologic patents has enabled manufacturers to enter the market and offer lower-cost alternatives of these drugs, according to the report. In-house manufacturing has become “increasingly popular” with biosimilar companies, according to the report. million by 2032, at 17.6 percent CAGR between 2023 and 2032.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ESG in pharma: Meeting increasing requirements in the Nordic region

Pharmaceutical Technology

Nordic healthcare providers are leading the momentum in enhancing ESG considerations. We examine the regional developments that will provide a competitive edge to pharma manufacturers.

Pharma 52
article thumbnail

Getting ahead of regulatory changes around PFAS in pharmaceutical packaging

Clarivate

1] To mitigate the potential presence of nitrosamine impurities in pharmaceuticals, manufacturers are now facing impending regulatory requirements in various markets – in the European Union, for example, they were obligated to submit reformulation strategies and mitigation plans in late 2022. [2].

article thumbnail

Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

PM360

In 2017, Algeria imposed importation restrictions on medicinal products that could be manufactured domestically, forcing manufacturers to establish local manufacturing facilities or to work with a contract manufacturing organization (CMO).

article thumbnail

Embracing digitalization in the pharmaceutical supply chain

Pharmaceutical Technology

“There are already opportunities for patients to track their health through smart medical devices sending reports directly to their healthcare provider. These healthcare providers will offer telemedicine, allowing remote patient monitoring from the comfort of the patients’ own homes. Disruptive technologies.

article thumbnail

Why script-to-dispense conversion will take centre stage in 2023

pharmaphorum

In 2023, expect manufacturers to further shift their focus away from acquiring new patient prescriptions to retaining existing customers. Manufacturers can use 2023 as a time to examine these and other causes of patient drop-off in greater detail, and develop actionable solutions for each product in their portfolio. in 1979 to 2.8%in